Defect‐Mediated Polarization Switching in Ferroelectrics and Related Materials: From Mesoscopic Mechanisms to Atomistic Control

The plethora of lattice and electronic behaviors in ferroelectric and multiferroic materials and heterostructures opens vistas into novel physical phenomena including magnetoelectric coupling and ferroelectric tunneling. The development of new classes of electronic, energy‐storage, and information‐technology devices depends critically on understanding and controlling field‐induced polarization switching. Polarization reversal is controlled by defects that determine activation energy, critical switching bias, and the selection between thermodynamically equivalent polarization states in multiaxial ferroelectrics. Understanding and controlling defect functionality in ferroelectric materials is as critical to the future of oxide electronics and solid‐state electrochemistry as defects in semiconductors are for semiconductor electronics. Here, recent advances in understanding the defect‐mediated switching mechanisms, enabled by recent advances in electron and scanning probe microscopy, are discussed. The synergy between local probes and structural methods offers a pathway to decipher deterministic polarization switching mechanisms on the level of a single atomically defined defect.     

Effects of some chelating agents on urinary copper excretion by the rat

In order to estimate the potential advantages of new chelating agents which can enhance copper excretion in the chronic copper intoxication arising in Wilson's disease, the relative ability of none chelating agents to induce the urinary excretion of copper was compared with that of D-penicillamine (DPA) and triethylenetetramine.2HCl (TRIEN), all given ip at 1 mmol/kg to male Sprague-Dawley rats. The compounds examined were as follows: tris(2-aminoethyl)-amine.3HCl (TREN), tetraethylenepentamine.5HCl (TETREN), pentaethylenehexamine.6HCl (PENTEN), 1,4,7,11-tetraazaundecane.4HCl (TAUD), 1,5,8,12-tetraazadodecane.4HCl (TADD), 1-N-benzyltriethylenetetramine.4HCl (BzTT), 4,7,10,13-tetraazatridecanoic acid.2H2SO4 (TTPA), 1,10-bis(2-pyridylmethyl)-1,4,7,10-tetraazadecane.4HCl (BPTETA), and N,N-bis(2-pyridylmethyl)-4-(aminomethyl)benzoic acid (4ABA). Of these, BzTT, TTPA, and 4ABA are new chelating agents not previously reported. The factors by which these chelating agents enhanced copper excretion over control (untreated) levels were as follows: DPA, 7.2; TREN, 1.6; TRIEN, 4.0; TETREN, 10.1; PENTEN, 7.8; TAUD, 7.8; TADD, 2.6; TTPA, 5.6; BzTT, 1.8; and 4ABA, 5.5. The results indicate that it may well be possible to develop additional chelating agents which are equal or superior to those now used in the treatment of Wilson's disease, as well as structural types whose immunological properties may be significantly different from DPA or TRIEN, the compounds currently used in the clinic for this disorder.     

A performance index for semicoherent structures

The index introduced here provides a normalized measure of the effectiveness of any semicoherent structure. We study the mathematical properties of the index and derive different axiomatic characterizations for it. Moreover, close relationships are shown to reliability functions and also to the Birnbaum structural importance measure—for which twice the performance index plays the role of potential function—that give rise to computational procedures. Some numerical examples illustrate the application of the index.     

Direct Observation of Inherent Atomic‐Scale Defect Disorders responsible for High‐Performance Ti1−xHfxNiSn1−ySby Half‐Heusler Thermoelectric Alloys

Structural defects often dominate the electronic‐ and thermal‐transport properties of thermoelectric (TE) materials and are thus a central ingredient for improving their performance. However, understanding the relationship between TE performance and the disordered atomic defects that are generally inherent in nanostructured alloys remains a challenge. Herein, the use of scanning transmission electron microscopy to visualize atomic defects directly is described and disordered atomic‐scale defects are demonstrated to be responsible for the enhancement of TE performance in nanostructured Ti_1?x Hf_x NiSn_1?y Sb_y half‐Heusler alloys. The disordered defects at all atomic sites induce a local composition fluctuation, effectively scattering phonons and improving the power factor. It is observed that the Ni interstitial and Ti,Hf/Sn antisite defects are collectively formed, leading to significant atomic disorder that causes the additional reduction of lattice thermal conductivity. The Ti_1?x Hf_x NiSn_1?y Sb_y alloys containing inherent atomic‐scale defect disorders are produced in one hour by a newly developed process of temperature‐regulated rapid solidification followed by sintering. The collective atomic‐scale defect disorder improves the zT to 1.09 ± 0.12 at 800 K for the Ti_0.5Hf_0.5NiSn_0.98Sb_0.02 alloy. These results provide a promising avenue for improving the TE performance of state‐of‐the‐art materials.     

Effect of V2O5 Doping on the Sintering and Dielectric Properties of M-Phase Li1+x−yNb1−x−3yTix+4yO3 Ceramics

The effect of the addition of V₂O₅ on the structure, sintering and dielectric properties of M -phase (Li_{1+ x − y} Nb_{1− x −3 y} Ti _x +4 _y )O₃ ceramics has been investigated. Homogeneous substitution of V⁵⁺ for Nb⁵⁺ was obtained in LiNb_{0.6(1− x )}V_{0.6 x} Ti_0.5O₃ for x ≤ 0.02. The addition of V₂O₅ led to a large reduction in the sintering temperature and samples with x = 0.02 could be fully densified at 900°C. The substitution of vanadia had a relatively minor adverse effect on the microwave dielectric properties of the M -phase system and the x = 0.02 ceramics had [alt epsilon]_r= 66, Q × f = 3800 at 5.6 GHz, and τ_f= 11 ppm/°C. Preliminary investigations suggest that silver metallization does not diffuse into the V₂O₅-doped M -phase ceramics at 900°C, making these materials potential candidates for low-temperature cofired ceramic (LTCC) applications.     

Atomic‐Level Sculpting of Crystalline Oxides: Toward Bulk Nanofabrication with Single Atomic Plane Precision

The atomic‐level sculpting of 3D crystalline oxide nanostructures from metastable amorphous films in a scanning transmission electron microscope (STEM) is demonstrated. Strontium titanate nanostructures grow epitaxially from the crystalline substrate following the beam path. This method can be used for fabricating crystalline structures as small as 1–2 nm and the process can be observed in situ with atomic resolution. The fabrication of arbitrary shape structures via control of the position and scan speed of the electron beam is further demonstrated. Combined with broad availability of the atomic resolved electron microscopy platforms, these observations suggest the feasibility of large scale implementation of bulk atomic‐level fabrication as a new enabling tool of nanoscience and technology, providing a bottom‐up, atomic‐level complement to 3D printing.     

Synthesis of new hole-transporting molecular glass with pendant carbazolyl moieties

The synthesis and properties of amorphous hole-transporting 4,4′-bis[11-carbazol-9-yl)-6,8,10-tri(carbazol-9-methyl)-3-hydroxy-5,7,9-trioxa-1-thia]thiobisbenzene with two end and six pendant carbazolyl moieties, separated from the main chain by CH₂ spacers, is reported. It was prepared by a multistep synthesis route from 1,6-di(carbazol-9-yl)-5-(carbazol-9-methyl)-4-oxa-2-hexanol glycidyl ether. Glass transition temperatures of intermediate and final products established by differential scanning calorimetry are reported. The hole drift mobility, measured by the time of flight technique, in this well defined molecular glass depends little on the strength of the electric field and exceeds 10⁻⁵ cm² V⁻¹ s⁻¹. The ionization potentials measured by electron photoemission method, light absorption and fluorescence spectra are closed to those reported for the other organic photoconductors containing electronically isolated carbazole moieties.     

Synthetic gas production by dry reforming of methane over Ni/Al2O3–ZrO2 catalysts: High H2/CO ratio

Alumina prepared by the sol-gel method, was impregnated with zirconia (5, 15 and 30 wt.%). Subsequently, the resulting Al₂O₃–ZrO₂ supports were impregnated with 15% Ni to obtain the Ni/Al₂O₃–ZrO₂ catalysts. The obtained catalysts were characterized by BET, SEM, XRD, H₂-TPR and TPD- CO₂. The catalytic activity was studied by means of dry reforming of methane (DRM) for syngas production. The catalysts displayed different physicochemical properties and trends of their catalytic activity as a function of the ZrO₂ content in the mixed oxide supports. For instance, ZrO₂ (5 wt %) in the catalyst, led to enhanced concentration of the medium strength basic sites and increased specific surface area, yielding thus the best performance in the DRM, with low carbon deposition after 36 h of reaction, compared with the other catalysts. This indicates that during the DRM reaction, this catalyst can provide more surface oxygen to prevent carbon deposits that could deactivate the catalyst.     

The Efficacy of Anti-PD-L1 Treatment in Melanoma Is Associated with the Expression of the ECM Molecule EMILIN2

The use of immune checkpoint inhibitors has revolutionized the treatment of melanoma patients, leading to remarkable improvements in the cure. However, to ensure a safe and effective treatment, there is the need to develop markers to identify the patients that would most likely respond to the therapies. The microenvironment is gaining attention in this context, since it can regulate both the immunotherapy efficacyand angiogenesis, which is known to be affected by treatment. Here, we investigated the putative role of the ECM molecule EMILIN-2, a tumor suppressive and pro-angiogenic molecule. We verified that the EMILIN2 expression is variable among melanoma patients and is associated with the response to PD-L1 inhibitors. Consistently, in preclinical settings, the absence of EMILIN-2 is associated with higher PD-L1 expression and increased immunotherapy efficacy. We verified that EMILIN-2 modulates PD-L1 expression in melanoma cells through indirect immune-dependent mechanisms. Notably, upon PD-L1 blockage, Emilin2^−/− mice displayed improved intra-tumoral vessel normalization and decreased tumor hypoxia. Finally, we provide evidence indicating that the inclusion of EMILIN2 in a number of gene expression signatures improves their predictive potential, a further indication that the analysis of this molecule may be key for the development of new markers to predict immunotherapy efficacy.